Contact

We’re Here to Support Your Fasting & Longevity Journey

Whether you’re new to fasting, exploring advanced protocols, or simply curious about how we can help you live with more energy and clarity, we’d love to hear from you.

Unable to find form

The Fasting Treasure No where to found

heart health and fasting

Heart Health on IF: Blood Pressure, Lipids, Endothelium, and HRV

December 11, 20252 min read

Cardiovascular disease (CVD) is driven by a cluster of risks—hypertension, dyslipidemia, insulin resistance, visceral fat, and inflammation. Intermittent fasting (IF) can improve each lever, sometimes even without weight loss when you align meals earlier.

Blood pressure: small drops, big impact

Meta-analyses of IF show average 3–5 mmHg reductions in blood pressure (Harris et al., 2018; Cioffi et al., 2018). In early time-restricted eating (eTRE), men with prediabetes dropped systolic BP by ~10 mmHg while improving insulin sensitivity—despite no intentional calorie cut (Sutton et al., 2018). Lower insulin reduces renal sodium retention; less visceral fat reduces RAAS activation; endothelium performs better.

Lipids: triglycerides down, LDL down modestly, HDL steady/up

Across 5:2, ADF, and TRE trials, triglycerides typically fall 10–20% and LDL drops modestly; HDL is stable or edges up (Harris et al., 2018; Trepanowski et al., 2017). Pair IF with a Mediterranean-leaning diet (olive oil, fish, legumes, nuts) and the lipid changes are often larger—because diet quality matters as much as timing.

Endothelial function and inflammation

Fasted-state signaling lowers CRP, IL-6, TNF-α and improves nitric oxide bioavailability, which together support endothelial function (de Cabo & Mattson, 2019). Some early TRE studies report better 24-hour glucose profiles and HRV, indicating a calmer autonomic balance—another CVD-protective signal.

Visceral fat and fatty liver

IF preferentially reduces abdominal/visceral fat, a core engine of cardiometabolic risk. Small TRE studies and 5:2/ADF trials also show decreases in liver fat and improvements in ALT/AST—important because NAFLD accelerates atherosclerosis (Cioffi et al., 2018).

Practical heart-health playbook

  • Consider eTRE (8–10-hour window ending by 4–6 pm) for 4–8 weeks; reassess BP, lipids, fasting insulin/glucose.

  • Walk after meals (10–15 min) to flatten glucose peaks and lower post-prandial lipemia.

  • Mediterranean inside the window: fish 2–3×/week, olive oil, legumes, whole grains, vegetables, nuts; minimize ultra-processed foods.

  • Strength + steps: 2–3 days of lifting + 6–10k daily steps improves blood pressure and insulin sensitivity (additive with IF).

  • Electrolyte sanity: If you’re low-carb, include sodium/potassium-rich foods; dramatic sodium restriction + low insulin can be dizzying.

Medications and safety

IF can potentiate effects of antihypertensives and glucose-lowering drugs. If you take ACE inhibitors, ARBs, diuretics, insulin, or sulfonylureas, loop in your clinician when you start IF to avoid hypotension or hypoglycemia.

Bottom line

IF is a temporal therapy for heart health: it lowers BP, improves lipids, trims visceral fat, calms inflammation, and may enhance autonomic resilience. Combine it with Mediterranean eating and regular training for a potent, evidence-based CVD risk-reduction stack.

Selected references

  • Sutton EF et al. Early TRE improves BP/insulin. Cell Metab. 2018;27:1212–1221.e3.

  • Harris L et al. IF meta-analysis (weight & risk factors). Obes Rev. 2018;19:318–335.

  • Cioffi I et al. IF effects on cardio-metabolic health. Nutrients. 2018;10:349.

  • Trepanowski JF et al. ADF 12-month trial. JAMA Intern Med. 2017;177:930–938.

  • de Cabo R, Mattson MP. N Engl J Med. 2019;381:2541–2551.

heart healthhealth and fastingheart health and fasting
Back to Blog

COMPANY

Keep in Touch

Copyrights 2025 | Terms & Conditions

Disclaimer: The information available is for informational purpose only and not intended to diagnose, treat, cure, or prevent any disease.